C | D | G | P value | |
---|---|---|---|---|
EA | 5 (3–7) | 4 (2–5) | 4 (2–6) | 0.002 |
Incidence of EA(n = 51) | 29(56.9%) | 9(17.6%) | 21(41.2%) | < 0.001* |
Postoperative pethidine consumption(mg) | 93.7 ± 12 | 33.14 ± 18.6 | 40.5 ± 21.5 | < 0.001# |
Midazolam(mg) | 1.5(0–4) | 0(0–4) | 0(0–4) | 0.01 |
VAS 4 h | 4 (3–6) | 2 (1–3) | 2 (1–3) | < 0.001 |
VAS 8 h | 4 (3–5) | 2 (1–3) | 2 (1–4) | < 0.001 |
VAS 12 h | 4 (3–5) | 3 (2–4) | 3 (2–4) | < 0.001 |
Pairwise comparisons | ||||
D-G | D-C | G-C | ||
EA | 0.006 | < 0.001 | 0.023 | |
Postoperative pethidine consumption# | 0.117 | < 0.001 | < 0.001 | |
Midazolam | 0.439 | 0.003 | 0.03 | |
VAS 4 h | 0.413 | < 0.001 | < 0.001 | |
VAS 8 h | 0.306 | < 0.001 | < 0.001 | |
VAS 12 h | 0.391 | < 0.001 | < 0.001 |